EASD 2019: Cotadutide Appears Promising for Type 2 Diabetes, Obesity, and NASH
Tolerability was confirmed in Japanese preobese/obese subjects with type 2 diabetes.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.